{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:40:21Z","timestamp":1789033221452,"version":"build-2803163510"},"reference-count":34,"publisher":"AOSIS","issue":"0","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background: Epidemiological studies suggest that nyaope, a heroin-based drug, is widely used in South Africa. Yet few reliable research tools are available to assess treatment outcomes of users. The Opiate Treatment Index (OTI), a tool developed in Australia, could potentially facilitate research on context-specific South African treatment outcomes. However, we know little of its test-retest reliability.\n\nAim: This study aimed to assess the test-retest reliability of the OTI among a sample of nyaope users in Johannesburg.\n\nSetting: This study was conducted across three substance use treatment facilities in Johannesburg.\n\nMethods: The OTI was administered to 53 nyaope users at baseline and one week later. To determine the test-retest reliability of the OTI, the intra-class correlation coefficients (ICC) and the Brennan\u2013Prediger coefficients of the two interviews were calculated.\n\nResults: The ICC of the Q-scores from the data sets along with the Brennan\u2013Prediger coefficient for the substance use domain were calculated. The ICC for nyaope was 0.38. Brennan\u2013Prediger coefficients were as follows: alcohol \u2013 0.96, crack-cocaine \u2013 0.89, cannabis \u2013 0.92, methaqualone \u2013 0.85 and crystal methamphetamine \u2013 0.89.\n\nConclusion: A significant positive finding was the excellent test-retest reliability of the injecting and sexual behaviour domains and moderate reliability of the criminality, general health and social functioning domains.\n\nContribution: The results of this study provide insight into the reliability of this tool and for its use in future studies in the South African context.<\/jats:p>","DOI":"10.4102\/sajpsychiatry.v30i0.2087","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T08:19:36Z","timestamp":1707380376000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The test-retest reliability of the Opiate Treatment Index in nyaope users in Johannesburg"],"prefix":"10.4102","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0233-6627","authenticated-orcid":false,"given":"Kelebogile","family":"Pitsoane","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-8720","authenticated-orcid":false,"given":"Nirvana","family":"Morgan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-368X","authenticated-orcid":false,"given":"Sumaya","family":"Mall","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"ref0","unstructured":"Herman AA, Stein DJ, Seedat S, et al. The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J [serial online]. 2009 [cited 2021 Jul 02];99(5 Pt 2):339\u2013344. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3191537\/"},{"key":"ref1","unstructured":"Dada S, Burnhams NH, Erasmus J, et al. South African Community Epidemiology Network on Drug Use (SACENDU): Monitoring alcohol, tobacco and other drug use trends (South Africa): July\u2013December 2019\/Phase 47 [homepage on the Internet]. 2020 [cited 2021 Jul 02]. Available from: https:\/\/www.samrc.ac.za\/sites\/default\/files\/attachments\/2020-11-03\/SACENDUupdatePHASE47.pdf"},{"key":"ref2","unstructured":"Dada S, Burnhams NH, Erasmus J, et al. South African Community Epidemiology Network on Drug Use (SACENDU): Monitoring alcohol, tobacco and Other Drug use Trends (South Africa): April 2019\/Phase 44 [homepage on the Internet]. 2020 [cited 2021 Jul 02]. Available from: https:\/\/www.samrc.ac.za\/sites\/default\/files\/attachments\/2019-0304\/SACENDUupdateJan2019.pdf"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Terry-McElrath YM, O\u2019Malley PM, Johnston LD, et al. Longitudinal patterns of marijuana use across ages 18\u201350 in a US national sample: A descriptive examination of predictors and health correlates of repeated measures latent class membership. Drug Alcohol Depend. 2017;171:70\u201383. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.021","DOI":"10.1016\/j.drugalcdep.2016.11.021"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Whyte AJ, Torregrossa MM, Barker JM, et al. Editorial: Long-term consequences of adolescent drug use: Evidence from pre-clinical and clinical models. Front Beha Neurosci. 2018;12:83. https:\/\/doi.org\/10.3389\/fnbeh.2018.00083","DOI":"10.3389\/fnbeh.2018.00083"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Brook JS, Richter L, Rubenstone E. Consequences of adolescent drug use on psychiatric disorders in early adulthood. Ann Med. 2000;32(6):401\u2013407. https:\/\/doi.org\/10.3109\/07853890008995947","DOI":"10.3109\/07853890008995947"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lawrinson P, Ali R, Buavirat A, et al. Key findings from the WHO collaborative study on substitution therapy for opiate dependence and HIV\/AIDS. Addict. 2008;103(9):1484\u20131492. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02249.x","DOI":"10.1111\/j.1360-0443.2008.02249.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Adelekan M, Green A, Dasgupta N, et al. Reliability and validity of the Opiate Treatment Index among a sample of opiate users in the United Kingdom. Drug Alcohol Rev. 1996;15(3):261\u2013270. https:\/\/doi.org\/10.1080\/09595239600186001","DOI":"10.1080\/09595239600186001"},{"key":"ref8","unstructured":"Chou S-Y, Chan H-Y. The reliability and validity of the modified Chinese version of the Opiate Treatment Index. Taiwanese J Psychiatry (Taipei) [serial online]. 2015 [cited 2021 Jul 02];20(1):51\u201358. Available from: http:\/\/www.sop.org.tw\/sop_journal\/Upload_files\/29_1\/008.pdf"},{"key":"ref9","unstructured":"Gonz\u00e1lez-Saiz F, Garc\u00eda-Valderrama T. The Opiate Treatment Index (OTI) clinical interview: New evidence of its reliability and validity. Heroin Addict Relat Clin Probl. 2012;14(2):19\u201334."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. Br J Addict. 1992;87(5):733\u2013742. https:\/\/doi.org\/10.1111\/j.13600443.1992.tb02719.x","DOI":"10.1111\/j.1360-0443.1992.tb02719.x"},{"key":"ref11","unstructured":"Darke S, Hall W, Wodak A, et al. The Opiate Treatment Index (OTI) manual [homepage on the Internet]. 1991 [cited 2021 Jul 02]. Available from: https:\/\/ndarc.med.unsw.edu.au\/sites\/default\/files\/ndarc\/resources\/TR.011.pdf"},{"key":"ref12","unstructured":"Morgan N, Daniels W, Subramaney U. Clinical characteristics and treatment outcomes of women with heroin dependence in Johannesburg, South Africa. S Afr Med J. 2020;110(6):540\u2013545. https:\/\/doi.org\/10.7196\/SAMJ.2020.v110i6.14304"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Morgan N, Daniels W, Subramaney U. A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes. Compr Psychiatry. 2019;95:152137. https:\/\/doi.org\/10.1016\/j.comppsych.2019.152137","DOI":"10.1016\/j.comppsych.2019.152137"},{"key":"ref14","unstructured":"Michael RS. Measurement: Reliability and validity Y520 Strategies for educational inquiry [homepage on the Internet]. n.d. [cited 2021 Jul 02]. Available from: https:\/\/docplayer.net\/20847467-Measurement-reliability-and-validity.html"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Doi Y, Minowa M. Factor structure of the 12-item General Health Questionnaire in the Japanese general adult population. Psychiatry Clin Neurosci. 2003;57(4): 379\u2013383. https:\/\/doi.org\/10.1046\/j.1440-1819.2003.01135.x","DOI":"10.1046\/j.1440-1819.2003.01135.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kashyap GC, Singh SK. Reliability and validity of general health questionnaire (GHQ-12) for male tannery workers: A study carried out in Kanpur, India. BMC Psychiatry. 2017;17(1):102. https:\/\/doi.org\/10.1186\/s12888-017-1253-y","DOI":"10.1186\/s12888-017-1253-y"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"De Kock FS, G\u00f6rgens-Ekermans G, Dhladhla TJ. A confirmatory factor analysis of the General Health Questionnaire\u201328 in a Black South African sample. J Health Psychol. 2014;19(10):1222\u20131231. https:\/\/doi.org\/10.1177\/1359105313488972","DOI":"10.1177\/1359105313488972"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Shoukri MM, Asyali MH, Donner A. Sample size requirements for the design of reliability study: Review and new results. Stat Methods Med Res. 2004;13(4):251\u2013271. https:\/\/doi.org\/10.1191\/0962280204sm365ra","DOI":"10.1191\/0962280204sm365ra"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u2013174. https:\/\/doi.org\/10.2307\/2529310","DOI":"10.2307\/2529310"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"ref21","unstructured":"SAS Institute Inc. SAS Software for Windows. North Carolina: SAS Institute Inc.; 2010."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","DOI":"10.1001\/jama.2013.281053"},{"key":"ref23","unstructured":"Demetriou C, Ozer B, Essau CA. Self-report questionnaires. In: Cautin RL, Lilienfeld SO, editors. The encyclopedia of clinical psychology, first edition [homepage on the Internet]. John Wiley & Sons, Inc; 2015 [cited 2021 Jul 02]. Available from: https:\/\/bilgeuzun.com\/wp-content\/uploads\/2017\/10\/Self-Report-wbecp507.pdf"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Chen WJ, Fang C-C, Shyu R-S, et al. Self-reported drug use: How prevalent is under- reporting? Addict Behav. 2006;31(12):2304\u20132308. https:\/\/doi.org\/10.1016\/j.addbeh.2006.02.015","DOI":"10.1016\/j.addbeh.2006.02.015"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Fendrich M, Johnson TP, Wislar JS, et al. The utility of drug testing in epidemiological research: Results from a general population survey. Addiction. 2004;99(2): 197\u2013208. https:\/\/doi.org\/10.1111\/j.1360-0443.2003.00632.x","DOI":"10.1111\/j.1360-0443.2003.00632.x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kilian S, Swartz L, Dowling T, Dlali M, Chiliza B. The potential consequences of informal interpreting practices for assessment of patients in a South African psychiatric hospital. Soc Sci Med. 2014;106:159\u2013167. https:\/\/doi.org\/10.1016\/j.socscimed.2014.01.019","DOI":"10.1016\/j.socscimed.2014.01.019"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Napper LE, Fisher DG, Johnson ME, et al. The reliability and validity of drug users\u2019 self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350\u2013354. https:\/\/doi.org\/10.1016\/j.addbeh.2009.12.006","DOI":"10.1016\/j.addbeh.2009.12.006"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Martin GW, Wilkinson DA, Kapur BM. Validation of self-reported cannabis use by urine analysis. Addict Behav. 1988;13(2):147\u2013150. https:\/\/doi.org\/10.1016\/0306-4603(88)90004-4","DOI":"10.1016\/0306-4603(88)90004-4"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, et al. Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 2019;38(4):435\u2013442. https:\/\/doi.org\/10.1111\/dar.12922","DOI":"10.1111\/dar.12922"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Verdejo-Garcia A, Bechara A, Recknor E, et al. Executive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc. 2006;12(3):405\u2013415. https:\/\/doi.org\/10.1017\/S1355617706060486","DOI":"10.1017\/S1355617706060486"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Ndlovu NA, Morgan N, Malapile S, et al. Fronto-temporal cortical atrophy in \u2018nyaope\u2019 combination heroin and cannabis use disorder. Drug Alcohol Depend. 2021;221:108630. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108630","DOI":"10.1016\/j.drugalcdep.2021.108630"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Murphy DA, Hser Y-I, Huang D, et al. Self-report of longitudinal substance use: A comparison of the UCLA natural history interview and the addiction severity index. J Drug Issues. 2010;40(2):495\u2013516. https:\/\/doi.org\/10.1177\/002204261004000210","DOI":"10.1177\/002204261004000210"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2): 136\u2013142. https:\/\/doi.org\/10.1080\/13550280290049615","DOI":"10.1080\/13550280290049615"}],"container-title":["South African Journal of Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/sajp.org.za\/index.php\/sajp\/article\/view\/2087\/3245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:08:14Z","timestamp":1788865694000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajp.org.za\/index.php\/sajp\/article\/view\/2087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":34,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/sajpsychiatry.v30i0.2087","relation":{},"ISSN":["1608-9685","2078-6786"],"issn-type":[{"value":"1608-9685","type":"print"},{"value":"2078-6786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"article-number":"a2087"}}